SLE-key DA


Recognizing the clinical utility and adoption of the SLE-key® Rule Out test for the Rule Out of a diagnosis of SLE by Rheumatologists nationwide, ImmunArray® is developing iCHIP® tests to provide additional support to these physicians in the management of patients with SLE and SLE-related disorders.  It is well known that differential diagnosis along with the management of already diagnosed patients can be challenging, cumbersome and time consuming in the rheumatology setting. Simple tests to support differential diagnosis and evaluation of patients requiring additional follow-up and intervention will enable clinicians to more efficiently focus their activities and reduce costs to patients, payers and the healthcare system.